Radosław Pietrzak1, Tomasz M Książczyk1, Elżbieta Górska2, Łukasz A Małek3, Bożena Werner1. 1. Department of Pediatric Cardiology and General Pediatrics, Medical University of Warsaw, Żwirki i Wigury Street 63a, 02-091 Warsaw, Poland. 2. Department of Laboratory Diagnostics and Clinical Immunology of Developmental Age, Medical University of Warsaw, Żwirki i Wigury Street 63a, 02-091 Warsaw, Poland. 3. Department of Epidemiology, Cardiovascular Disease Prevention and Health Promotion, National Institute of Cardiology, Alpejska Street 42, 04-628 Warsaw, Poland.
Abstract
Galectin-3 (G3) is a biomarker known as an inflammatory state exponent. The aim of this paper was to analyze the G3 in adolescents with ventricular arrhythmia (VES) in order to evaluate its impact on myocardial tissue preservation. The study group (SG) consisted of 25 VES adolescents. The control group (CG) was 21 healthy children. G3 was assessed in the SG and CG. In the SG electrocardiography, Holter monitoring, echocardiography and CMR were performed. The G3 in SG was 13.45 ± 11.4 ng/mL and in CG 7.2 ± 2.0 ng/mL, p < 0.001. Moderate positive correlation between the G3 and z-score of the left ventricular diameter (r = 0.47, p = 0.041) and moderate negative correlation between the G3 and the left ventricular ejection fraction in cardiac magnetic resonance (CMR EF) (-0.49, p = 0.032) were found. According to the multiple linear regression analysis, CMR EF and VES were independent predictors for G3 elevation. Conclusion: Galectin-3 plasma concentration is elevated and correlates with the chosen left ventricular dysfunction parameters in adolescents suffering from ventricular arrhythmia. Further investigation is necessary to establish if elevated G3 is a useful biomarker for screening young individuals with ventricular arrhythmia who are at risk of structural cardiovascular pathology.
Galectin-3 (G3) is a biomarker known as an inflammatory state exponent. The aim of this paper was to analyze the G3 in adolescents with ventricular arrhythmia (VES) in order to evaluate its impact on myocardial tissue preservation. The study group (SG) consisted of 25 VES adolescents. The control group (CG) was 21 healthy children. G3 was assessed in the SG and CG. In the SG electrocardiography, Holter monitoring, echocardiography and CMR were performed. The G3 in SG was 13.45 ± 11.4 ng/mL and in CG 7.2 ± 2.0 ng/mL, p < 0.001. Moderate positive correlation between the G3 and z-score of the left ventricular diameter (r = 0.47, p = 0.041) and moderate negative correlation between the G3 and the left ventricular ejection fraction in cardiac magnetic resonance (CMR EF) (-0.49, p = 0.032) were found. According to the multiple linear regression analysis, CMR EF and VES were independent predictors for G3 elevation. Conclusion: Galectin-3 plasma concentration is elevated and correlates with the chosen left ventricular dysfunction parameters in adolescents suffering from ventricular arrhythmia. Further investigation is necessary to establish if elevated G3 is a useful biomarker for screening young individuals with ventricular arrhythmia who are at risk of structural cardiovascular pathology.
Authors: Wyman W Lai; Tal Geva; Girish S Shirali; Peter C Frommelt; Richard A Humes; Michael M Brook; Ricardo H Pignatelli; Jack Rychik Journal: J Am Soc Echocardiogr Date: 2006-12 Impact factor: 5.251
Authors: G Michael Felker; Mona Fiuzat; Linda K Shaw; Robert Clare; David J Whellan; Luca Bettari; Shailesh C Shirolkar; Mark Donahue; Dalane W Kitzman; Faiez Zannad; Ileana L Piña; Christopher M O'Connor Journal: Circ Heart Fail Date: 2011-10-20 Impact factor: 8.790
Authors: Tariq Ahmad; Mona Fiuzat; Benjamin Neely; Megan L Neely; Michael J Pencina; William E Kraus; Faiez Zannad; David J Whellan; Mark P Donahue; Ileana L Piña; Kirkwood F Adams; Dalane W Kitzman; Christopher M O'Connor; G Michael Felker Journal: JACC Heart Fail Date: 2014-06 Impact factor: 12.035
Authors: Timir S Baman; Dave C Lange; Karl J Ilg; Sanjaya K Gupta; Tzu-Yu Liu; Craig Alguire; William Armstrong; Eric Good; Aman Chugh; Krit Jongnarangsin; Frank Pelosi; Thomas Crawford; Matthew Ebinger; Hakan Oral; Fred Morady; Frank Bogun Journal: Heart Rhythm Date: 2010-03-27 Impact factor: 6.343
Authors: Muhammed U Yalcin; Kadri M Gurses; Duygu Kocyigit; Hande Canpinar; Ugur Canpolat; Banu Evranos; Hikmet Yorgun; Mehmet L Sahiner; Ergun B Kaya; Tuncay Hazirolan; Lale Tokgozoglu; Mehmet A Oto; Necla Ozer; Dicle Guc; Kudret Aytemir Journal: J Cardiovasc Electrophysiol Date: 2015-03-27
Authors: Lieke J J Klinkenberg; Peter Luyten; Noreen van der Linden; Kim Urgel; Daniëlle P C Snijders; Christian Knackstedt; Robert Dennert; Bastiaan L J H Kietselaer; Alma M A Mingels; Eline P M Cardinaels; Frederique E C M Peeters; Jeroen D E van Suijlen; Joop Ten Kate; Elke Marsch; Thomas L Theelen; Judith C Sluimer; Kristiaan Wouters; Otto Bekers; Sebastiaan C A M Bekkers; Luc J C van Loon; Marja P van Dieijen-Visser; Steven J R Meex Journal: Am J Cardiol Date: 2016-05-04 Impact factor: 2.778
Authors: Niklas Beyhoff; David Lohr; Anna Foryst-Ludwig; Robert Klopfleisch; Sarah Brix; Jana Grune; Arne Thiele; Lasti Erfinanda; Arata Tabuchi; Wolfgang M Kuebler; Burkert Pieske; Laura M Schreiber; Ulrich Kintscher Journal: Hypertension Date: 2019-07-10 Impact factor: 10.190
Authors: Yoshio Takemoto; Rafael J Ramirez; Miki Yokokawa; Kuljeet Kaur; Daniela Ponce-Balbuena; Mohamad C Sinno; B Cicero Willis; Hamid Ghanbari; Steven R Ennis; Guadalupe Guerrero-Serna; Bettina C Henzi; Rakesh Latchamsetty; Roberto Ramos-Mondragon; Hassan Musa; Raphael P Martins; Sandeep V Pandit; Sami F Noujaim; Thomas Crawford; Krit Jongnarangsin; Frank Pelosi; Frank Bogun; Aman Chugh; Omer Berenfeld; Fred Morady; Hakan Oral; José Jalife Journal: JACC Basic Transl Sci Date: 2016-04